Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire21-02-2023, 13:07
Coloplast A/S - Announcement no. 01/2023 – Interim 3-02-2023, 13:35